KRAS and non-small cell lung carcinoma: Although numerous studies have suggested that m6A methylation plays crucial roles in the occurrence and development of various cancer types, including NSCLC, the role of m6A methylation in chemoresistance in KRAS-mutant NSCLC remains elusive (19–21).